Schedule 13G ownership disclosure

Graf Acquisition Corp. IV

Security class unavailable · CUSIP: 384272100

Event date: 2021-07-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,104,647
Percent of class
5.1500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-21-003441
Form type
SC 13G
Filer
NKGen Biotech, Inc.
CIK
CIK 1845459
Filed
Jul 09, 2021
Reporting period
Jul 02, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub